Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates

Statistics in Medicine

Volumn 28, Issue 26, 2009, Pages 3249-3259

  Chiba, Yasutaka ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Causal inference; Intention to treat analysis; Per protocol analysis; Placebo effect; Potential outcomes

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; ATTRIBUTABLE RISK; CALCULATION; CAUSAL MODELING; CONFOUNDING VARIABLE; COVARIANCE; DIET THERAPY; ISCHEMIC HEART DISEASE; OBSERVATIONAL STUDY; PARTICIPANT OBSERVATION; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT REFUSAL;

ANTICHOLESTEREMIC AGENTS; BIOSTATISTICS; CLOFIBRATE; CORONARY DISEASE; HUMANS; INTERVENTION STUDIES; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 70449359840     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3724     Document Type: Article

References (30)

1. Fisher LD, Dixon DO, Herson J, Frankowski R, Hearron M, Peace KE. Intention-to-treat in clinical trials. In Statistical Issues in Drug Research and Development, Peace KE (ed.). Marcel Dekker: New York, 1990; 331-350.
2. Lee Y, Ellenberg J, Hirtz D, Nelson K. Analysis of clinical trials by treatment actually received: is it really an option? Statistics in Medicine 1991; 10:1595-1605. DOI: 10.1002/sim.4780101011.
3. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 1967; 20:637-648.
4. Sheiner L, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clinical Pharmacology and Therapeutics 1995; 57:6-15. DOI: 10.1016/0009-9236(95)90260-90270
5. Piantadoci S. Clinical Trials: A Methodologic Perspective. Wiley: New York, 1997.
6. Sommer A, Zeger S. On estimating efficacy from clinical trials. Statistics in Medicine 1991; 10:45-52. DOI: 10.1002/sim.4780100110.
7. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 1996; 91:444-455. DOI: 10.2307/2291629. (Pubitemid 126412813)
8. Robins JM, Tsiatis AA. Correcting for non-compliance in randomized trials using rank preserving structural failure time models. Communications in Statistics - Theory and Methods 1991; 20:2609-2631.
9. Mark SD, Robins JM. A method for the analysis of randomized trials with noncompliance information: an application to the multiple risk factor intervention trial. Controlled Clinical Trials 1993; 14:79-97.
10. Robins JM, Greenland S. Adjusting for differential rates of PCP prophylaxis in high- versus low-dose AZT treatment arms in an AIDS randomized trial. Journal of the American Statistical Association 1994; 89:737-749. (Pubitemid 24816604)
11. Sato T. Sample size calculations with compliance information. Statistics in Medicine 2000; 19:2689-2697. DOI: 10.1002/1097-0258(20001015)19:19〈2689: :AID-SIM555〉3.0.CO;2-0. (Pubitemid 30727399)
12. Matsui S. Stratified analysis in randomized trials with noncompliance. Biometrics 2005; 61:816-823. DOI: 10.1111/j.1541-0420.2005.00339.x. (Pubitemid 41805856)
13. Robins JM, Greenland S. Discussion of 'Identification of causal effects using instrumental variables'. by Angrist JD, Imbens GW, Rubin DB. Journal of the American Statistical Association 1996; 91:456-458.
14. Greenland S. An introduction to instrumental variables for epidemiologists. International Journal of Epidemiology 2000; 29:722-729.
15. Bollen KA. Structural equation models. In Encyclopedia of Biostatistics (2nd edn), Armitage P, Colton T (eds). Wiley: New York, 2005; 5269-5278.
16. Robins JM. The analysis of randomized and non-randomized AIDS treatment trials using a new approach to causal inference in longitudinal studies. In Health Service Research Methodology: A Focus on AIDS, Sechrest L, Freeman H, Mulley A (eds). U.S. Public Health Service: Washington, DC, 1989; 113-159.
17. Manski CF. Nonparametric bounds on treatment effects. American Economic Review 1990; 80:319-323.
18. Pearl J. Causal inference from indirect experiments. Artificial Intelligence in Medicine 1995; 7:561-582.
19. Balke A, Pearl J. Bounds on treatment effects from studies with imperfect compliance. Journal of the American Statistical Association 1997; 92:1171-1176. (Pubitemid 127119877)
20. Pearl J. Causality: Models, Reasoning, and Inference. Cambridge University Press: Cambridge, 2000.
21. Chiba Y, Sato T, Greenland S. Bounds on potential risks and causal risk differences under assumptions about confounding parameters. Statistics in Medicine 2007; 26:5125-5135. DOI: 10.1002/sim.2927. (Pubitemid 350148470)
22. VanderWeele TJ. The sign of the bias of unmeasured confounding. Biometrics 2008; 64:702-706. DOI: 10.1111/j.1541-0420.2007.00957.x.
23. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology 1974; 66:688-701.
24. Rubin DB. Bayesian inference for causal effects: the role of randomization. Annals of Statistics 1978; 6:34-58.
25. Rubin DB. Formal models of statistical inference for causal effects. Journal of Statistical Planning and Inference 1990; 25:279-292.
26. Esary JD, Proschan F, Walkup DW. Association of random variables, with applications. Annals of Mathematical Statistics 1967; 38:1466-1474.
27. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. Journal of the American Medical Association 1982; 248:1465-1477.
28. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. New England Journal of Medicine 1980; 303:1038-1041.
29. World Health Organization. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up: Report of the Committee of Principal Investigators. Lancet 1980; 316:379-385.
30. Lewis JA, Machine D. Intention-to-treat-who should use ITT? British Journal of Cancer 1993; 68:647-650.